Canadian Allergy Treatment Market size was valued at USD XX Billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of XX% from 2019 to 2028.

Allergies are hypersensitive responses from the human immune system to the substance that come in contact with the body. Severe allergy can be life-threatening, disturbing the normal functioning of organs such as asthma causes poor lung functioning. In 2017, 27.3% of Canadians aged 12 and older (roughly 8.4 million people) reported having allergies. Overall, females (28.9%) were more likely to report having allergies than males (25.6%). Canadians most commonly reported being allergic to pollens or grasses (40.7%), followed by certain animals (28.5%), dust mites (27.3%), and certain medications (28.0%). Among allergy sufferers, roughly 3.6 million people (42.8%) reported being allergic to multiple allergens. The primary symptoms of allergic reactions include itching in the nose, the roof of the mouth, throat, eyes, sneezing, stuffy nose (congestion), teary eyes, etc. In addition, food allergies can cause symptoms such as vomiting, diarrhoea, or respiratory symptoms, after ingestion of an allergen. Increased prevalence of allergens and high consumption of tobacco can induce several allergies to drive the growth of the Canadian allergy treatment market.



Market Drivers

The rapidly growing heavy environmental pollutants, changing lifestyles, low-quality dietary habits, and the existence of a variety of communicable and non-communicable diseases further complicate the prevalence of allergic diseases in Canada. The key factors that drive the Canadian allergy treatment market include a significant increase in allergic diseases, a rise in preferences toward over-the-counter drugs for allergy treatment, and a surge in self-medication in consumers. However, increased usage of biosimilars and safety & efficacy concerns regarding the side effects associated with vigorous consumption of anti-allergy drugs are anticipated to hamper the growth of the allergy treatment market. On the contrary, increased R&D and a rise in awareness among healthcare professionals and patients regarding immunotherapy to treat allergies are expected to create lucrative opportunities in the future.